• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Avoca Group holds Quality Summit

Avoca Group holds Quality Summit

May 28, 2013
CenterWatch Staff

The Avoca Group, a Princeton, N.J.-based consulting and research organization specializing in clinical outsourcing and alliance management, held its second annual Avoca Quality Consortium Summit May 8 and 9. Last year, Avoca formed the industry‐wide Avoca Quality Consortium, bringing together quality, outsourcing and operational professionals from member pharma, biotech and CROs to accelerate the development of a best practice approach to quality management and oversight of outsourced clinical research.

The Summit engaged more than 100 senior executives from large to small pharma companies and leading service providers in discussions on effective clinical trial oversight, risk assessment and risk management, change management and creating a culture of quality.

The consensus: The industry must move toward a more proactive approach to quality management and risk management. While no “one size fits all” formula can be applied to all organizations, the Consortium has been able to bridge gaps and develop mutually agreed upon standards of quality that have a built‐in flexibility with tailored modules that companies can adapt and implement to meet their organization’s needs and pave the way for improved outcomes.

This year, the Consortium, which now has more than 30 sponsor and CRO member companies, is focusing on creating specific guidelines and tools for proactive quality management and effective oversight. It also has conducted an assessment on member company approaches to risk assessment, management and sharing in outsourced clinical trials. Avoca is collaborating with the Metrics Champion Consortium and participates in ongoing discussions with CTTI and Transcelerate to ensure no duplication of efforts.

“Providing insights, standards and tools for proactive quality management and effective oversight will have a significant, positive impact on the industry in terms of ensuring efficiency while focusing on maintaining high quality,” said Patricia Leuchten, CEO of The Avoca Group.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing